share_log

Recursion Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144

Recursion Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144

Recursion Pharmaceuticals | 144:拟议出售证券
美股SEC公告 ·  08/14 16:43
Moomoo AI 已提取核心信息
Recursion Pharmaceuticals, Inc. officer Secora Michael is set to sell 15,000 Class A shares on 08/14/2024, with an aggregate market value of $95,251.36. The shares were acquired through stock option exercises on 06/14/2023 and 07/18/2023, with a total of 11,537 and 3,463 shares respectively, both purchased with cash from the issuer. This planned sale follows a history of selling 75,000 shares over the past three months, generating total gross proceeds of $592,415.84. The notice of the upcoming sale was filed on the same date as the planned sale, with the initial plan adoption or instruction given on 03/01/2024.
Recursion Pharmaceuticals, Inc. officer Secora Michael is set to sell 15,000 Class A shares on 08/14/2024, with an aggregate market value of $95,251.36. The shares were acquired through stock option exercises on 06/14/2023 and 07/18/2023, with a total of 11,537 and 3,463 shares respectively, both purchased with cash from the issuer. This planned sale follows a history of selling 75,000 shares over the past three months, generating total gross proceeds of $592,415.84. The notice of the upcoming sale was filed on the same date as the planned sale, with the initial plan adoption or instruction given on 03/01/2024.
Recursion Pharmaceuticals, Inc.的高管Secora Michael计划在2024年08月14日出售15,000股A类股票,市场价值为$95,251.36。该股票是通过2023年06月14日和2023年07月18日的股票期权行权获得的,分别总共购买了11,537股和3,463股,均采用现金从发行方购买。此次计划销售是在过去三个月出售75,000股股票的基础上进行的,总共获得了$592,415.84的总收入。计划销售通知与计划销售的同一天提交,初始计划采用或指令给出于2024年03月01日。
Recursion Pharmaceuticals, Inc.的高管Secora Michael计划在2024年08月14日出售15,000股A类股票,市场价值为$95,251.36。该股票是通过2023年06月14日和2023年07月18日的股票期权行权获得的,分别总共购买了11,537股和3,463股,均采用现金从发行方购买。此次计划销售是在过去三个月出售75,000股股票的基础上进行的,总共获得了$592,415.84的总收入。计划销售通知与计划销售的同一天提交,初始计划采用或指令给出于2024年03月01日。
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息